Nov 08, 2023 / 10:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q2 FY24 earnings conference call of J B Chemicals and Pharmaceuticals Ltd. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Jason D'Souza, Executive Vice President, J.B Pharma. Thank you and over to you.
Jason D'Souza - J B Chemicals and Pharmaceuticals Ltd - EVP, IR
Thanks, Yashisri. Welcome to J.B. Pharma's Q2 earnings call. I would like to introduce the management who is present at this call. We have Mr. Nikhil Chopra, CEO and Whole-Time Director of J.B, Pharma; Mr. Kunal Khanna, President, Operations J.B. Pharma; and Lakshya Kataria, CFO, J.B. Pharma. I would like to hand this over to Mr. Nikhil Chopra for his opening remark. Over to you sir.
Nikhil Chopra - J B Chemicals and Pharmaceuticals Ltd - Chief Executive Officer, Whole-time Director
Thank you, Jason, and a big welcome to all of you for the conference call for J.B. Pharma. Overall, we had gathered to discuss the operating and
Q2 2024 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot